Interventionalists treating patients suffering from Peripheral Vascular Disease (PVD) in the Superficial Femoral Artery (SFA) require a flexible stent-graft capable of re-lining tortuous arteries.

The GORE® VIABAHN® Endoprosthesis is constructed with a durable, reinforced, biocompatible, expanded polytetrafluoroethylene (ePTFE) liner attached to an external nitinol stent structure. The extreme flexibility of the GORE® VIABAHN® Endoprosthesis enables it to better traverse tortuous areas of the SFA and conform more closely to the complex anatomy of the artery.

The GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface is approved for endovascular grafting of the peripheral arteries. This stent-graft features the addition of proprietary heparin-bonded technology to the proven combination of ePTFE and nitinol. End-point covalent bonding keeps heparin anchored to the endoprosthesis surface while the bioactive site remains free to interact with the blood.

With a lower-profile, streamlined delivery system, the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface makes it easier to reach and treat challenging SFA lesions.

One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN® Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease

New clinical study shows excellent patency consistent with previous study results of self-expanding stent-graft in long, complex SFA lesions

GORE® VIABAHN® Endoprosthesis Marks 20 Years of Proven Performance

Market-leading stent-graft has evolved to address range of indications, patient needs

GORE VIABAHN Endoprosthesis